Skip to main content
Top
Published in: Lung 1/2017

01-02-2017

Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea

Authors: Laszlo Kunos, Zsofia Lazar, Fruzsina Martinovszky, Adam D. Tarnoki, David L. Tarnoki, Daniel Kovacs, Bianka Forgo, Peter Horvath, Gyorgy Losonczy, Andras Bikov

Published in: Lung | Issue 1/2017

Login to get access

Abstract

Purpose

Obstructive sleep apnoea (OSA) is a prevalent disorder, characterised by collapse of the upper airways during sleep. The impact of sleep-disordered breathing on pulmonary function indices is however currently not well described. The aim of the study was to evaluate diurnal change in lung function indices in a cohort of patients with OSA and relate pulmonary function changes to disease severity.

Methods

42 patients with OSA and 73 healthy control subjects participated in the study. Asthma and COPD were excluded in all volunteers following a clinical and spirometric assessment. Spirometry was then performed in all subjects in the evening and the morning following a polysomnography study.

Results

There was no difference in evening or morning FEV1 or FVC between patients and control subjects (p > 0.05). Neither FEV1 nor FVC changed in control subjects overnight (p > 0.05). In contrast, FEV1 significantly increased from evening (2.18/1.54–4.46/L) to morning measurement (2.26/1.42–4.63/L) in OSA without any change in FVC. The FEV1 increase in OSA was related to male gender, obesity and the lack of treatment with statins or β-blockers (all p < 0.05). A tendency for a direct correlation was apparent between overnight FEV1 change and RDI (p = 0.05, r = 0.30).

Conclusions

Diurnal variations in spirometric indices occur in patients with OSA and FEV1 appears to increase in subjects with OSA overnight. These changes occur in the absence of change in FVC and are directly related to the severity of OSA. These findings dictate a need to consider time of lung function measurement.
Literature
3.
go back to reference Onal E, Leech JA, Lopata M (1985) Relationship between pulmonary function and sleep-induced respiratory abnormalities. Chest 87(4):437–441CrossRefPubMed Onal E, Leech JA, Lopata M (1985) Relationship between pulmonary function and sleep-induced respiratory abnormalities. Chest 87(4):437–441CrossRefPubMed
4.
go back to reference Abdeyrim A, Li N, Shao L, Heizhati M, Wang Y, Yao X, Abulikemu S, Zhang D, Chang G, Yin T, Li C, Meng J, Zhao M, Zhou L, Hong J, Zhang Y (2016) What can impulse oscillometry and pulmonary function testing tell us about obstructive sleep apnea: a case–control observational study? Sleep Breath 20(1):61–68. doi:10.1007/s11325-015-1185-z CrossRefPubMed Abdeyrim A, Li N, Shao L, Heizhati M, Wang Y, Yao X, Abulikemu S, Zhang D, Chang G, Yin T, Li C, Meng J, Zhao M, Zhou L, Hong J, Zhang Y (2016) What can impulse oscillometry and pulmonary function testing tell us about obstructive sleep apnea: a case–control observational study? Sleep Breath 20(1):61–68. doi:10.​1007/​s11325-015-1185-z CrossRefPubMed
6.
go back to reference Bednarek M, Plywaczewski R, Jonczak L, Zielinski J (2005) There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 72(2):142–149. doi:10.1159/000084044 CrossRefPubMed Bednarek M, Plywaczewski R, Jonczak L, Zielinski J (2005) There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 72(2):142–149. doi:10.​1159/​000084044 CrossRefPubMed
9.
go back to reference Kunos L, Bikov A, Lazar Z, Korosi BZ, Benedek P, Losonczy G, Horvath I (2015) Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose. Sleep Breath 19(1):247–253. doi:10.1007/s11325-014-1003-z CrossRefPubMed Kunos L, Bikov A, Lazar Z, Korosi BZ, Benedek P, Losonczy G, Horvath I (2015) Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose. Sleep Breath 19(1):247–253. doi:10.​1007/​s11325-014-1003-z CrossRefPubMed
10.
go back to reference Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386–1392CrossRefPubMed Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386–1392CrossRefPubMed
11.
go back to reference Chua AP, Aboussouan LS, Minai OA, Paschke K, Laskowski D, Dweik RA (2013) Long-term continuous positive airway pressure therapy normalizes high exhaled nitric oxide levels in obstructive sleep apnea. J Clin Sleep Med 9(6):529–535. doi:10.5664/jcsm.2740 PubMedPubMedCentral Chua AP, Aboussouan LS, Minai OA, Paschke K, Laskowski D, Dweik RA (2013) Long-term continuous positive airway pressure therapy normalizes high exhaled nitric oxide levels in obstructive sleep apnea. J Clin Sleep Med 9(6):529–535. doi:10.​5664/​jcsm.​2740 PubMedPubMedCentral
12.
go back to reference Olopade CO, Christon JA, Zakkar M, Hua C, Swedler WI, Scheff PA, Rubinstein I (1997) Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111(6):1500–1504CrossRefPubMed Olopade CO, Christon JA, Zakkar M, Hua C, Swedler WI, Scheff PA, Rubinstein I (1997) Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111(6):1500–1504CrossRefPubMed
13.
go back to reference Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945CrossRefPubMed Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945CrossRefPubMed
14.
go back to reference Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR (1993) Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103(3):722–727CrossRefPubMed Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR (1993) Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103(3):722–727CrossRefPubMed
16.
go back to reference Cabezas GA, Graf PD, Nadel JA (1971) Sympathetic versus parasympathetic nervous regulation of airways in dogs. J Appl Physiol 31(5):651–655PubMed Cabezas GA, Graf PD, Nadel JA (1971) Sympathetic versus parasympathetic nervous regulation of airways in dogs. J Appl Physiol 31(5):651–655PubMed
17.
go back to reference Larsson K (1985) Studies of sympatho-adrenal reactivity and adrenoceptor function in bronchial asthma. Eur J Respir Dis Suppl 141:1–52PubMed Larsson K (1985) Studies of sympatho-adrenal reactivity and adrenoceptor function in bronchial asthma. Eur J Respir Dis Suppl 141:1–52PubMed
19.
go back to reference Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28(4):499–521PubMed Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28(4):499–521PubMed
20.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338. doi:10.1183/09031936.05.00034805 CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Force AET (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338. doi:10.​1183/​09031936.​05.​00034805 CrossRefPubMed
22.
go back to reference Borsboom GJ, van Pelt W, van Houwelingen HC, van Vianen BG, Schouten JP, Quanjer PH (1999) Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis. Am J Respir Crit Care Med 159(4):1163–1171. doi:10.1164/ajrccm.159.4.9703106 CrossRefPubMed Borsboom GJ, van Pelt W, van Houwelingen HC, van Vianen BG, Schouten JP, Quanjer PH (1999) Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis. Am J Respir Crit Care Med 159(4):1163–1171. doi:10.​1164/​ajrccm.​159.​4.​9703106 CrossRefPubMed
23.
go back to reference Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14(1):83–86PubMed Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14(1):83–86PubMed
24.
go back to reference Horner RL, Brooks D, Kozar LF, Tse S, Phillipson EA (1995) Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 79(1):151–162PubMed Horner RL, Brooks D, Kozar LF, Tse S, Phillipson EA (1995) Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 79(1):151–162PubMed
27.
go back to reference Barnes PJ, Fitzgerald GA, Dollery CT (1982) Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci 62(4):349–354CrossRefPubMed Barnes PJ, Fitzgerald GA, Dollery CT (1982) Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci 62(4):349–354CrossRefPubMed
28.
go back to reference Kapsimalis F, Kryger MH (2002) Gender and obstructive sleep apnea syndrome, part 2: mechanisms. Sleep 25(5):499–506PubMed Kapsimalis F, Kryger MH (2002) Gender and obstructive sleep apnea syndrome, part 2: mechanisms. Sleep 25(5):499–506PubMed
31.
go back to reference Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA (2004) Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 101(14):4948–4953. doi:10.1073/pnas.0400452101 CrossRefPubMedPubMedCentral Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA (2004) Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 101(14):4948–4953. doi:10.​1073/​pnas.​0400452101 CrossRefPubMedPubMedCentral
33.
go back to reference Joos GF, O’Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R, Postma DS, Riedler J (2003) Indirect airway challenges. Eur Respir J 21(6):1050–1068CrossRefPubMed Joos GF, O’Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R, Postma DS, Riedler J (2003) Indirect airway challenges. Eur Respir J 21(6):1050–1068CrossRefPubMed
Metadata
Title
Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea
Authors
Laszlo Kunos
Zsofia Lazar
Fruzsina Martinovszky
Adam D. Tarnoki
David L. Tarnoki
Daniel Kovacs
Bianka Forgo
Peter Horvath
Gyorgy Losonczy
Andras Bikov
Publication date
01-02-2017
Publisher
Springer US
Published in
Lung / Issue 1/2017
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9957-1

Other articles of this Issue 1/2017

Lung 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.